The scheme seeks to generate capital appreciation by investing in a concentrated portfolio of equity and equity related securities of up to 30 companies across market capitalization i.e. focus on multicap.
Expense Ratio | 0.65 % |
Launched | - |
AUM in Crores | 10484.4 |
ISIN | INF109K018N2 |
Lock-in (days) | No Lock-in |
Benchmark | BSE 500 Total Return Index |
SIP Minimum | 1000 |
Lumpsum Min. | 5000 |
Standard Deviation (3yr) | - |
Standard Deviation | 13.6 |
Beta | 0.9 |
Sharpe Ratio | 0.9 |
YTM | - |
ICICI Bank Ltd.
8.33%Sun Pharmaceutical Industries Ltd.
7.21%Infosys Ltd.
4.47%Larsen & Toubro Ltd.
4.3%HDFC Bank Ltd.
3.92%Financial
27.96%Healthcare
11.38%Construction
9.5%Energy
6.58%Services
6.45%Fund Name | Fund Size | |
---|---|---|
₹ 49,131 cr | ||
₹ 93,440 cr | ||
₹ 64,962 cr | ||
₹ 27,730 cr | ||
₹ 16,217 cr |